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Summary The bacterial immunopotentiator OK-432 induced natural killer cell activating factor (NKAF)
from mouse spleen cells. OK-432-induced NKAF showed a single peak with an apparent mol. wt of 70Kd by
Sephadex G-100 chromatography and OK-432-induced interleukin 2 (IL-2) had the same mol. wt as NKAF.
However, OK-432-induced interferon (IFN) showed molecular heterogeneity with two peaks at 90Kd and
45Kd. Further purification was achieved by Blue Sepharose affinity chromatography which copurified NKAF
and IFN. The affinity-purified NKAF, however, was stable to heat (560C) and acid (pH 2) treatments.
Moreover, anti-IFN failed to abolish NKAF activity and this activity was not absorbed by IL-2 dependent T
cells. From isoelectric focusing analysis, a dissociation of NKAF and IFN was observed over the range ofpl
6.5 to 8.0. Based on these results, KNAF appears to be a new kind of cytokine distinguishable from IFN and
IL-2.
Lymphoid cells from many mammalian species
exhibit spontaneous cell-mediated cytotoxicity
against a variety of syngeneic, allogeneic and xeno-
geneic tumour target cells. The effector cells
mediating spontaneous cytotoxicity have been
designated natural killer (NK) cells, because of
their natural tumoricidal capacity without any
apparent presensitization (Pross et al., 1977). There
is strong evidence that NK cells infiltrate the
tumour site (Flannery et al., 1981; Moore & Moore,
1979) and play a role in protection against tumour
growth (Habu et al., 1981), and against metastasis
of transplantable tumours (Hanna, 1980; Talmadge
et al., 1980). NK cells also have the ability to kill
freshly isolated autologous tumour cells (Uchida et
al., 1983b). Recently, substantial interest has been
generated in soluble factors and agents which
influence the level of NK cell-mediated cytotoxicity.
Murine NK activity has been shown to be
enhanced by a variety of immunoregulating
substances such as interferon (Gidlund et al., 1978),
interleukin 2 (Henney et al., 1981) and thymic
factor (Dominique et al., 1983).
OK-432 is the one of the biological response
modifiers which has been extensively used for
malignant diseases. This agent has been found to
enhance NK activity both in humans (Uchida &
Mickshe, 1981) and in mice (Oshimi et al., 1980).
OK-432 also induces interleukin 2 (IL-2) and
interferon (IFN) from human peripheral blood
lymphocytes (Wakasugi et al., 1982) and IFN from
mouse spleen cells (Saito et al., 1982). In the
murine system, however, spleen cell-derived NK cell
activating factor induced by OK-432 stimulation
has not been fully characterized. In order to
investigate the factor most responsible for NK cell
activation by OK-432, we have studied the culture
supernatants of OK-432-stimulated mouse spleen
cells. As we report here, a soluble factor which
demonstrates properties distinct from IFN and IL-2
plays an essential role in NK cell activation by OK-
432.
Materials and methods
Mice and tumour cells
Specific pathogen free BALB/c mice (6 to 8 week-
old female) were obtained from Charles River
Japan, Inc. (Atugi, Japan). YAC-1 lymphoma cells
were used as NK target cells and L929 cells were
used for IFN assay. YAC-1 cells were maintained
in RPMI 1640 medium (GIBCO, Grand Island,
NY) supplemented with 10% heat-inactivated foetal
calf serum (FCS, GIBCO) and 60 ugml-1
kanamycin (Meiji Seika Co., Ltd., Tokyo). L929
cells were cultured in minimum essential medium
(MEM, Nissui Co., Ltd., Tokyo) supplemented
with 5% FCS.
Stimulants
OK-432, a penicillin- and heat-treated, lyophilized
preparation of the low virulence Su strain of
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Streptococcus pyogenes group A3 (Chugai
Pharmaceutical Co., Ltd., Tokyo, Japan), with KE
(Klinische Einheit) unit corresponding to 0.1 mg
dried streptococci, was suspended in physiological
saline for in vivo administration and in RPMI
medium for in vitro use. Concanavalin A (Con A)
was purchased from Sigma Chemical Company
(Saint Louis, MO).
Preparation ofNKAF containing splenocyte culture
supernatantsfor gelfiltration
Spleens were obtained from 400 mice 4 days after
i.p. injection of OK-432 (1 KE/mouse). The single
cell suspension was prepared by pressing the tissue
through a fine mesh screen into MEM. Splenocytes
were washed twice with MEM and suspended at a
concentration of 107cellsml- in RPMI 1640
medium supplemented with 1% FCS (1% FCS-
RPMI). The cell suspension was distributed in
30ml aliquots into 75cm2 plastic culture flasks
(Corning Glass Works, Corning, NY) and
incubated with OK-432 (0.05KEml- 1) for 24h at
37°C in a humidified atmosphere containing 5%
CO2' Then the culture supernatants were collected
by centrifugation at 220g for 10min. To remove
OK-432 particles, an additional centrifugation at
12,000g for 30min was performed.
Sephadex G-100 chromatography
Cell free supernatants were precipitated by 80%
ammonium sulphate at 4°C for 24h. After centri-
fugation at 12,000g for 30min, the pellets were
redissolved in 0.1 M PBS (pH 7.4) and dialyzed
against the same buffer overnight at 4°C, then
concentrated 100-fold from the starting supernatant
volume by polyethylene glycol 20,000 (Wako Pure
Chemical Ind., Osaka, Japan). Fifteen mililiters of
concentrated materials (44mgml-1) were dialyzed
against running buffer (0.1 M PBS, pH 7.4
containing 0.5M NaCl and 0.02% NaN3), applied
onto the Sephadex G-100 column (6 x 150cm) and
eluted in 14ml fractions at a flow rate of
57.1 mlh-1. Then, 1 ml of each fraction was
dialyzed against RPMI 1640 medium overnight,
filtered and assayed for NKAF activity. Apparent
mol. wt was estimated by comparison with the
standard proteins: blue dextran (200Kd), bovine
serum albumin (BSA, 67Kd), ovalbumin (OVA,
45Kd), chymotrypsinogen (CHY, 23Kd) and ribo-
nuclease A (RIB, 13Kd) [(Low Mol. Wt Calibration
Kit (Pharmacia Fine Chemicals, Uppsala,
Sweden))].
Blue Sepharose CL-6B affinity chromatography
Sephadex-active NKAF fractions (fr. 55-65) were
collected and purified by affinity chromatography
according to the methods of Stefanos et al. (1980).
Briefly, Blue Sepharose CL-6B resin (Pharmacia
Fine Chemicals) was washed with 100 column
volumes of starting buffer El (0.02 M PBS, pH 7.4)
and packed into a 12 x 61 mm column. Then 2ml of
active materials (38mgml-1) dialyzed against El
buffer was applied to the column and washed with
10 column vols of starting buffer El. After
washing, the absorbed materials were eluted with a
discontinuous NaCl gradient: second buffer E2
(0.2MNaCl), third buffer E3 (1.5 MNaCl) and
final buffer E4 (50% v/v ethylene glycol in E3
buffer). The flow rate was 2.2mlh 1 and each
fraction was 1.06ml.
Isoelectricfocusing-polyacrylamide gel
electrophoresis (IEF-PAGE)
The pI of NKAF was determined by IEF-PAGE.
The gels (5%, 80mm) contained 2% ampholytes
(pH 3-10, Bio-Rad Laboratories, Richmond, CA)
and were polymerized with riboflavin-5-phosphate
(5 x 10-6%), ammonium persulfate (2 x 10-4%)
and with light for 3h. Samples were dialyzed
against distilled water, and then glycerol (15% v/v)
and ampholytes (2% v/v) were added. Then, 100p1
aliquot of samples were applied to the gels and
overlayered first with 100p1 of 5% glycerol and 2%
ampholytes and second with upper buffer (0.02M
H2S04). The lower buffer was 1 M NaOH. The gels
were electrophoresed at a constant voltage of 200v
for 24h at 4°C, removed and sliced into 3mm
sections, and placed in tubes containing degassed
distilled water. The tubes were tightly capped and
incubated overnight at 4°C to elute NKAF. The
pH of each sample was measured and eluants were
dialyzed against distilled water overnight at 4°C.
Then all samples were lyophilized, and 300 u1 of
RPMI 1640 medium added to each fraction.
Determination ofNKAF activity
Splenocytes of BALB/c mice were suspended at a
concentration of 1.35 x107cellsml-1 in 10% FCS-
RPMI medium. An aliquot (75p1) of effector cell
suspension was placed into a 96 well round bottom
microplate (Nunclon, Nunc Inter Med., Denmark).
Effector cells were preincubated with NKAF
containing samples (25% v/v) at 37°C for 3h. After
preincubation, 5'Cr-labelled YAC-1 target cell
suspension (100p1wellP1) was added to each well.
The cells were incubated at 37°C for an additional
4h. Then 100p1 of supernatant was removed and
the radioactivity determined in a gamma counter.
Spontaneous release was determined for 100/p1 of
target cells incubated in medium alone and totalCHARACTERIZATION OF NKAF 99
incorporated cpm were determined for 100 1l of
target cell suspension. The percentage of specific
cytolysis was calculated using the following
formula:
% specific cytolysis
Experimental cpm - Spontaneous cpm
Total Incorporated cpm- Spontaneous cpm
x 100
NKAF activity was assayed in triplicate.
Determination ofIFN activity
IFN activity was determined byusingthe 50% plaque
reduction method on mouse L929 cells with
vesicular stomatitis virus added to the microculture
plate as described by Koi et al. (1981). IFN activity
was expressed in international reference units based
on an NIH reference mouse IFN (NIH No. G-002-
904-511). All samples were assayed in duplicate.
Determination ofIL-2 activity
The IL-2 dependent allogeneic killer T cell line,
Clone 902, which was established from mixed
lymphocyte cultures of A/J mouse spleen cells
immunized with C57BL/6 mouse spleen cells, had
been maintained in our laboratories over 6 months
in the presence of rat IL-2. The IL-2 dependent
cells were washed 3 x with MEM prior to IL-2
assay and suspended in 5% FCS-RPMI medium
and placed in a 96 well round bottom microculture
plate (104cells/well); then, IL-2 containing samples
were added to the microculture at a concentration
of 10% (v/v) in 200Iu1 of final volume. Micro-
cultures were incubated with 1.0pCi 3H-thymidine
for the last 4h of the 48 h incubation and were
harvested on glass fibre filters by using the LABO
MASH semi-automatic cell harvester (Labo Science,
Tokyo, Japan). Incorporation of radioactivity was
determined by scintillation counting in a toluene
base scintillator. IL-2 activity was expressed as the
mean incorporated cpm of triplicate assay.
IL-2 absorption assay
IL-2 dependent cells were washed 3 x with IL-2
free MEM to remove remaining IL-2. Then the cell
pellets (104-107 cells) were incubated in test sample
solution (1 ml) at 4°C for 4h to allow absorption.
The supernatants were removed by centrifugation at
220g for 5min and bioassayed for NKAF and IL-2
activity.
Heat treatment
Samples were incubated at 56°C for 30min or
60min in a water bath to compare the stability of
NKAF and IFN. After incubation, heat-treated
materials were immediately cooled in ice for later
use.
Anti-IFN serum and IFN
Anti-IFN oc/,B (NIH No. G024-501-568) was kindly
provided by Dr K. Pauker, Medical College of
Pennsylvania, Philadelphia, PA. Anti-IFNy, a
rabbit antiserum against mouse lymphocyte IFN
which is induced by Staphyloccoccal enterotoxin A
(Langford et al., 1981) was supplied by Dr M.P.
Langford, University of Texas, Galveston, TX. L
cell-derived IFN(specific activity 2.2 x 108 unitsml-1,
Torey Industries, Inc., Japan) was a kind gift of Dr
N. Ishida, Tohoku University School of Medicine,
Sendai, Japan.
Acid treatment
The samples were dialyzed against 0.01 M glycine-
HCl pH 2 buffer at 4°C for 24h to inactivate IFNy.
To neutralize to pH7.2, an additional dialysis was
performed against RPMI 1640 medium at 4°C
overnight.
Results
Induction ofNKAFfrom OK-432-stimulated mouse
spleen cells
Spleen cells of BALB/c mice injected with OK-432
(1 KE/mouse, i.p.) were isolated 1-7 days after
injection and stimulated with OK-432 or Con A.
Each 24h culture supernatant was assayed for
NKAF activity. As shown in Figure 1, untreated
mouse spleen cells produced NKAF in response to
stimulation by OK-432. However, from days 3-5,
spleen cells of OK-432 treated mice showed levels
of NKAF production higher than did untreated
mouse spleen cells. The maximum NKAF
production was observed in the supernatant ofDay-
4 spleen cells. In contrast to OK-432 stimulation,
Con A failed to elicit NK-enhancing substances
from OK-432 injected mouse spleen cells at levels
higher than from untreated mouse spleen cells.
Induction kinetics ofNKAF
In order to compare the induction kinetics of
NKAF with those of IFN, spleen cell suspensions
of untreated or OK-432 injected (Day-4) mice
(107cellsml-l in 1% FCS-RPMI medium) were
incubated with OK-432 (0.05KEml-1) at 37°C for
24h, then each culture supernatant was assessed for
NKAF and IFN activity. NKAF activity was
detectable as early as 1 h after OK-432 stimulation
and maximum NKAF production was observed in
the culture supernatant of Day-4 splenocytes after
24h incubation. The splenocytes of untreated mice100 0. ICHIMURA et al.
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Figure 1 Augmentation of NKAF production by OK-432 administration. Spleen cells of BALB/c mice given
an i.p. injection of OK-432 (1 KE/mouse) after 1-7 days were stimulated with OK-432 (0.05KEml-1, I),
Con A (5pgml-', !) or medium alone (El) for 24h. Each culture supernatant was assayed for NKAF
activity at an E:T ratio of 50:1. Values represent mean + s.d. oftriplicate assay.
showed kinetically different NKAF production
from that of Day-4 splenocytes, because untreated
mouse splenocytes demonstrated levels of NKAF
production at 24h of cultivation lower than those
of 4-day splenocytes and higher levels of NKAF
production after 48h incubation. In contrast to
NKAF production, both splenocyte preparations
showed the same IFN production kinetics. IFN
activity was detectable at 7h after OK-432
stimulation, reached a plateau after 12h and
remained unchanged for at least 48h (Figure 2).
Dose-dependent NKAFproduction in response to
OK-432 stimulation
To investigate the dose-dependency of NKAF
production in response to OK-432 stimulation in
vitro, the untreated mouse splenocytes and Day-4
splenocytes (107cellsml-1 in 1% FCS-RPMI
medium) were incubated with OK-432 (5 x 10-4,
5x 10-3 or 5x 10-2KEml-1) or medium alone for
24h. As shown in Figure 3, Day 4 splenocytes
showed levels of NKAF production higher than
untreated mouse splenocytes at the concentration of
5 x10-3 and 5 x 10-2KEml-1. However, both
splenocyte populations demonstrated dose-
dependent NKAF production in response to
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Figure 2 Induction kinetics of NKAF and IFN.
Spleen cells of untreated mice and Day-4 mice were
incubated with OK-432 (0.05 KEml-1) for 1-48h.
Each culture supernatant was assayed for NKAF and
IFN activity. NK activity in the presence of culture
supernatants of untreated mice spleen cells (0), Day-4
mice spleen cells (0) or medium alone (OZ). Each
value represents mean + s.d. of triplicate assay at an
E:T ratio of 50:1. IFN activity of untreated (O) or
Day-4 mice (1) culture supernatants.CHARACTERIZATION OF NK1AF 101
I
22 e
n._
20- 0. 16+ cm
t :
X- 16+-4
0
co 12 -
z
10 -
0
P
>
0 5x<10- 5x10-3 5x10-2
OK-432 concentration (KE ml-1)
- 300
- U2
-200 -c
.
-t 100 >
t co
z
* <20-
Figure 3 OK-432 dose-dependent NKAF production
by spleen cells. NK activity in the presence of culture
supernatants of untreated mice (0), Day-4 mice (0)
splenocytes incubated with vanrous concentrations of
OK-432 (5 x 10-4 to 5 x 10-2KEml-1) or medium
alone (E). Each value represents mean + s.d. of
tnplicate assay at an E:T ratio of 50:1. IFN activity
of untreated mice ([O1) and Day-4 mice (U) spleno-
cytes culture supernatants.
the concentration of OK-432. In contrast to
NKAF production, there was not a significant
difference in IFN production by each splenocyte
population: IFN activity was detectable at a
concentration of 5 x 10-3 KErnl - 1 and reached a
plateau at a concentration of 5xlO-2KEmlV-.
Although repeated injections of OK-432
(1 KE/mouse, i.p.) enhanced IFN production by
spleen cells following stimulation of OK-432 or
Con A in vitro (Saito et al., 1983), a single injection
of OK-432 failed to enhance IFN production.
Nevertheless, a single injection of OK-432 enhanced
NKAF production to the rechallenge of OK-432 in
vitro.
Augmentation kinetics ofNK activity by NKAF
containing culture supernatants
In order to investigate the augmentation kinetics of
NK activity by NKAF, 24h culture supernatants of
Day-4 splenocytes stimulated with OK-432
(0.05 KEml-1) concentrated by 80% ammonium
sulphate (2.2mgml-1), or L cell-derived IFN
(3,400 unitsml- 1) were added to fresh splenocytes
at 25% v/v, incubated at 37 C for 0 to 20h, then
assayed for NK activity. As shown in Figure 4,
NKAF containing supernatants caused significant
boosting of NK activity without preincubation.
Maximum augmentation of NK activity was
detected at 3 h preincubation. IFN-induced NK cell
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Ftgre 4 Augmentation kinetics of NK activity by
NKAF-containing culture supernatants. Fresh spleen
cells were incubated with NKAF containing culture
supernatants (Day-4 spleen cell-derived, with 1020
unitsml-l IFN activity, (0), IFN (El) or medium
alone (0) for 0-20h prior to NKAF assay. Each
value represents mean + s.d. triplicate assay at an
E:T ratio of 50:1.
activation showed kinetics resembling those of
NKAF containing supernatants; reaching a plateau
at 3 h preincubation and slightly decreasing at 20h.
Sephadex G-1JO chromatography ofNKAF
In order to investigate the mol. wt of OK-432
induced NKAF, culture supernatants from Day 4
spleen cells stimulated with OK-432 (0.05 KEml-1,
24h), conditions which demonstrated maximum
NKAF production, were concentrated and
chromatographed on a Sephadex G-100 column. A
major peak of NKAF was observed at an apparent
mol. wt of -70 Kd coinciding with the mol. wt of
OK-432-induced IL-2. However, OK-432-induced
IFN showed molecular heterogeneity: two peaks at
- 80Kd and 45Kd. From the results of gel
filtration, the mol. wt of NKAF correlated well
with IL-2 but not with IEN (Figure 5).
Failure ofNKAF to be absorbed by IL-2 dependent
cells
By Sephadex G-100 chromatography, NKAF and
OK-432-induced IL-2 were known to have a closely
related mol. wt of 70 Kd. To investigate the
relationship of NKAF and IL-2, the Sephadex102 0. ICHIMURA et al.
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Figure 5 Sephadex G-100 chromatography of OK-432-induced NKAF. Culture supernatants of Day-4
splenocytes stimulated with OK-432 (0.05 KEml 1) for 24h were prepared for chromatography on Sephadex
G-100 as described in Materials and methods. Each fraction was assayed for NKAF activity (0), IFN activity
(B) and IL-2 activity (O). NK activity incubated with medium alone was 1l.5+ 1.7 B.
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active NKAF fractions (fr. 55-65) were collected
and dialyzed against RPMI medium. Then the
active materials were incubated with IL-2
dependent cells (104-107cellsml-P) at 4°C for 4h.
After incubation, each supernatant was assayed for
NKAF and IL-2 activity. As shown in Table I,
NKAF activity remained unchanged even after
incubation with IL-2 dependent cells. Before IL-2
absorption, the materials did not demonstrate any
significant IL-2 activity in spite of the IL-2 peak
fraction obtained by gel filtration. We observed
that OK-432-induced IL-2 showed 10 or more times
less activity than Con A-induced IL-2 in
unseparated culture supernatants (Ichimura et al.,
1983) and was liable to concentration and dialysis
procedures (data not shown). Nevertheless NKAF
activity was present in concentrate materials and
was not absorbed by IL-2 dependent cells.
Blue Sepharose CL-6B affinity chromatography of
Sephadex active NKAF
IFNy can be selectively purified by Blue Sepharose
affinity chromatography (Stefanos et al., 1980). In
order to remove IFNy from NKAF containing
materials, Sephadex active NKAF fractions (fr. 55-
65) were pooled, concentrated (38 mgml-1), and
loaded on to an affinity column. As shown in
Figure 6, NKAF and IFN were eluted in the same
fraction by E3 buffer (1.5 M NaCl containing PBS).
IL-2 activity was not observed in any
fractions.
Stabilities ofaffinity-purified NKAF and the
anti-IFN serum treatment
To compare the physicochemical properties of
NKAF and IFN, the affinity-purified NKAF
fraction (fraction E3) was treated with heat (56°C,
30min or 60min) and acid (pH 2, 24h). As shown
in Table II, NKAF activity remained unchanged
after either treatment; however, IFN was sensitive
to both heat and acid treatments. Nevertheless,
high titres of IFN activity still remained after acid
and heat treatment (320unitsml-1 and
640unitsml-1 respectively). It is possible that
residual IFN affects NK cell activity. In order to
investigate this possibility, anti-IFN serum was
added to the acid-treated materials to neutralise
residual IFN activity. Although anti-IFNy
completely neutralized IFN activity, it failed to
abolish NKAF activity. Anti-IFN a/# did not
neutralize IFN activity but reduced NKAF activity
to the same extent as anti-IFNy. Since the partial
reduction of NKAF activity by anti-IFN serum was
not correlated with neutralization of IFN activity,
NKAF was distinguishable from IFN by its
antigenicity.
Effect ofNKAFpresence or absence in cytotoxic
assay
In order to investigate whether or not the presence
of NKAF in the cytotoxic assay is a pre-requisite
for augmentation of NK activity, spleen cells were
incubated with affinity-purified NKAF at 25% v/v
for 3h, washed once and assessed for NK activity.
As shown in Table III, the presence of NKAF
throughout the cytotoxic assay resulted in a higher
level of NK-boosting activity than the absence of
NKAF. However, an appreciable level of NK-
boosting activity remained after the washing out of
NKAF prior to the cytotoxic assay.
Table I Failure ofIL-2 dependent cells to absorb NKAF
Absorbed CTLL Residual NK4Factivitya Residual IL-2 activityb
cell number (% specific killing) (incorporated cpm)
107 22.2+0.67 94+22c
5x106 24.6+1.05 54+ 6c
106 21.4+2.33 59+ 5c
5x105 21.1+2.95 59+ 3c
10s 26.6+1.89 76+ 15c
5 x 104 25.3+0.35 70+ 7c
104 24.6+ 1.48 84+ 13c
0 20.9+1.92 58+ 17c
Medium alone 7.8+0.99 112+25
Sephadex G-100 active NKAF fraction (fr. 55-65) was incubated with
IL-2 dependent T cells at 4°C for 4h.
aEach value represents mean+s.d. oftriplicate assay at an E:T ratio of
50:1.
bEach value represents mean + s.d. of triplicate assay.
cValue was insignificant from medium control.104 0. ICHIMURA et al.
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Figure 6 Blue Sepharose affinity chromatography of Sephadex G-100 active NKAF fraction. Sephadex G-
100 active NKAF fraction (fr. 55-65) was prepared for chromatography on Blue Sepharose CL-6B. Absorbed
materials were eluted with a discontinuous NaCl gradient (El buffer, 0.02M PBS, pH 7.4; E2 buffer, 0.2M
NaCl PBS; E3 buffer, 1.5 M NaCl PBS; E4 buffer, 50% v/v ethylene glycol in E3 buffer). Each fraction was
assayed for NKAF activity (0) and IFN activity (0). NK activity incubated with medium alone was
10.8 +0.7 H.
Table II Stabilities and anti-IFN serum treatments of affinity-purified
NKAF
Residual NKAFactivityb Residual IFN activity
Treatment' (% specific killing) (initsml-1)
Untreated 11.1+0.36 1280
Heat 56°C, 30min 12.1 +0.95 640
60min 10.4+0.17 640
Acid pH 2, 24h 10.4+0.14 320
+anti-IFN a/flC 8.6+ 1.27 320
+anti-IFN yd 7.5+ 1.27 <20
Medium alone 0.2+0.58
'Blue Sepharose active NKAF fraction E3 was treated.
bEach value represents mean + s.d. of triplicate assay at an E:T ratio
of 50: 1.
cAnti-IFN a/fi was equivalent to 100,000 neutralizing units ml- .
dAnti-IFN y was equivalent to 320 neutralizing units ml-'.
-
0
Co4CHARACTERIZATION OF NKAF 105
Table III NKAF presence or absence in cytotoxic assay
NK activity (% specific Iysis)a
Medium alone NKAFpresenceb NKAF absencec
Exp. Vd
3h preincubation 1.5+0.07 12.7+0.43 7.1 +0.38
Exp. 2'
24h preincubation 4.8+0.89 23.1 +0.98 17.0+0.41
aEach value represents mean + s.d. of triplicate assay.
bBlue Sepharose partially purified NKAF (0.42mgml-' with 1020
unitsml-1 of IFN activity) present in cytotoxic assay after 3h
preincubation.
'Preincubated cells were washed once prior to NK assay.
dE:T ratio was 33:1.
eE:T ratio was 50:1.
Augmentation ofsplenic and lymphatic NK activity
but not thymic NK activity by NKAF
In order to elucidate the organ distribution of
NKAF-reactive effector cells other than spleno-
cytes, thymocytes and mesenteric lymph node cells
were used as effector cells, preincubated with
affinity-purified NKAF fr. E3 at various NKAF
concentrations for 3 h and assessed for NK activity.
As shown in Figure 7, thymocytes failed to react
with NKAF but NK activity of mesenteric lymph
node cells as well as splenocytes were augmented by
NKAF in a dose-dependent fashion. These findings
show the lack of NKAF-reactive effector cells in
thymus but not in mesenteric lymph node and
spleen.
Isoelectricfocusing (IEF)-PAGE ofaffinity-purified
NKAF
Because IEF possesses a relatively high degree of
resolving power for the separation of proteins of
similar, but not identical charge, it has been quite
useful in comparative studies of the biological
activities present in the same cell culture
supernatants. It was of interest to compere the pl of
NKAF and IFNy. The affinity-purified NKAF
fraction was first dialyzed against distilled water, a
procedure which did not significantly affect NKAF
activity (data not shown). The dialyzed materials
were then electrophoresed for 18h at a constant
voltage of 200v at 4°C. As shown in Figure 8,
NKAF showed charge heterogeneity, with two
major peaks (pl 4.0-6.0 and pl 6.5-8.0). Affinity-
purified IFN, however, had an acidic pl 4.0-6.0
only. These findings demonstrate that NKAF could
be partially separated from IFN by IEF-PAGE.
Discussion
We found that an IL-2 and IFN-independent
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Figure 7 In vitro augmentation of splenic and lymph
node NK activity but not thymic NK activity by
NKAF. Spleen, mesenteric lymph node and thymus
cells were incubated with affinity purified NKAF
(0.42mgml- , with 1020unitsml- l of IFN activity) at
various diluted concentrations as indicated in figure
for 3h prior to NK assay. NK activity of spleen (0),
mesenteric lymph node (A) and thymus (m) cells were
expressed as mean + s.d. of triplicate assay at an E:T
ratio of 33:1.
pathway in the process of NK cell activation by
OK-432 exists which is mediated by a new kind of
soluble factor termed NKAF. This conclusion was
based on the results from the following
m x Thy i R106 0. ICHIMURA et al.
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Figure 8 Isoelectric focusing PAGE of affinity-purified NKAF. Affinity-purified NKAF (fr. E3) was
electrophoresed by IEF-PAGE as described in Materials and methods. Each fraction was assayed for NKAF
activity (0) at an E:T ratio of 50:1 and for IFN activity (0). NK activity incubated with medium alone was
10.7+ 1.5.
experiments: (i) the induction kinetics and the
optimal concentration of OK-432 for the
production of NKAF were different from those of
IFN (Figures 2, 3) and single i.p. injection of OK-
432 caused enhancement of NKAF production but
not IFN in response to in vitro OK-432 stimulation
(Figures 2, 3). (ii) NKAF and OK-432-induced IL-2
demonstrated the same mol. wt 70Kd, however,
OK-432-induced IFN showed molecular hetero-
geneity by gel filtration analysis (Figure 5). (iii)
Although affinity-purified IFN was labile to heat
(56°C) and acid (pH 2) treatments, NKAF was not
affected by these treatments. Moreover, an
additional anti-IFN antiserum treatment failed to
abolish NKAF activity (Table II). (iv) NKAF
demonstrated charge heterogeneity in IEF-PAGE
experiments. Furthermore, a dissociation of NKAF
and IFN was observed over the pl range of 6.5 to
8.0 (Figure 8).
In the human system, Uchida et al. (1981)
reported IL-2- and IFN-independent NK cell
activation by OK-432. Their finding that anti-IFN
serum failed to inhibit NK cell activation by OK-
432 correlated well with our observations. In
contrast to our present results, Wakasugi et al.
(1982) reported the participation of IL-2 and IFN
in NK cell activation by OK-432: IL-2, IFNcx and
IFNy were induced in culture supernatants of OK-
432-stimulated human peripheral lymphocytes.
These discrepancies may result from differences in
species, in the preparation of OK-432-stimulated
culture supernatants, or in the time of pretreatment
of effector cells (24h). We used the culture super-
natant of OK-432-pretreated (Day-4) mouse spleno-
cytes as a source of NKAF and employed a short
term preincubation (3h) system. According to
Henney et al. (1981), IL-2-induced boosting of NK
activity is observed after 16h of culture. More than
6h of preincukation is required for recombinant
IFNy-induced NK cell activation (John R. Ortaldo,
personal communication) but not for recombinant
IFNa, a protein which causes augmentation of NK
activity, within hours (Herberman et al., 1982).
OK-432-induced IFN, copurified with NKAF, was
gamma type because of its acid susceptibility and
antigenicity (Table II). These findings suggest that
contaminating IFNy and IL-2 do not affect NKAF
activity in a short term preincubation system; even
so, we could not dismiss the possibility that
contaminating IFNy and IL-2 may have altered the
sensitivity of our effector cells to NKAF.
Although the cellular origin of NKAF remains
unclear, our recent studies suggest that thymus-
derived lymphocytes may be the NKAF producer
cells, because thymocytes produce NKAF-like
factor in response to OK-432 stimulation in vitro.
This factor resembles spleen-cell derived NKAF in
terms of its chromatographic behaviour, but differs
in terms of its antigenicity to IFN and IL-2, among
other characteristics. I.p. administration of OK-432
prior to in vitro restimulation by OK-432 failed to
augment IFN production but did augment NKAFCHARACTERIZATION OF NKAF 107
production. These observations led us to suggest
that a single injection of OK-432 is sufficient for
NKAF induction but not for IFN induction and,
furthermore, that the induction mechanisms might
be different from each other. As previously
reported, a single i.p. injection of OK-432 enhanced
both interleukin 1 (IL-1) and IL-2 production in
response to the in vitro rechallenge of OK-432
(Ichimura et al., 1983). These interleukins may
participate in NKAF production, since IL-1
augments IL-2 production and IL-2 regulates IFNy
production by T cells (Farrar et al., 1982).
The presence of NKAF throughout the cytotoxic
assay resulted in higher levels of NK augmentation
than did the absence of NKAF even after 24h of
preincubation (Table III). NKAF did not
demonstrate any direct cytotoxicity against YAC-1
target cells in a 4h chromium release assay (data
not shown). These observations suggest that NKAF
might affect not only NKAF-responsive effector
cells but also effector to target interaction or target
susceptibility to NK cell-mediated cytolysis.
NKAF preparations augmented splenic and
mesenteric lymph node NK cell activity in a dose
dependent manner but not thymic NK cell activity
(Figure 7). In the human system, OK-432 can
activate peripheral blood and lymph node NK cell
activity by in vitro stimulation. However, IFN
failed to activate lymph node NK cell activity
(Uchida et al., 1984). Our preliminary observation
that murine NKAF enhanced human peripheral
blood NK cell activity (data not shown) led us to
the speculation that the mechanisms of NKAF-
induced NK cell activation might be different from
those of IFN-induced NK cell activation which is a
well documented species-specific phenomenon
(Heron et al., 1979; Herberman et al., 1982).
In human cancer patients, intrapleural
administration of OK-432 resulted in an induction
or augmentation of effusion NK cell activity along
with reduction or disappearance of effusion tumour
cells. Autologous tumour killer cells induced by
OK-432 demonstrated NK cell morphological
characteristics (Uchida et al., 1983a). These clinical
findings suggest that NK cell activation is most
responsible for the anti-tumour effect of OK-432.
In conclusion, our observations indicate that the
regulation of mouse NK activity in vitro is complex
and subject to the participation of NKAF as well
as IFN and IL-2 in OK-432 stimulation. These
findings provide the basis for future studies on the
modulation of NK activity.
We thank Dr N. Ishida for kindly supplying antiserum
against mouse IFN. We also wish to thank Dr M. Saito
for his technical advice and Dr A. Uchida for helpful
suggestions.
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